UNSPSC 51273902: Aloe/benzocaine/lanolin/menthol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE700. This VA Drug Class (DE700) classifies this compound as belonging to the group LOCAL ANESTHETICS, TOPICAL.

UNSPSC 51273902 Aloe/benzocaine/lanolin/menthol is a Commodity code that in recent state and local procurement activity reflects a mismatch between the nominal code title and what is actually being solicited. The code's name suggests topical analgesic and soothing agents, but recent opportunities tagged under it include naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products—none of which align with the code's stated commodity scope. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving multiple states including Oregon). The geographic spread covers Florida, Texas, Minnesota, and Oregon based on recent activity.

Representative recent solicitations include Seminole County's IFB60459723LAS, posted June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and an IFB response deadline of July 26, 2023; the Texas Health and Human Services Commission's RFI HHS0017013, posted April 3, 2026, gathering vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802, posted January 20, 2026, for generic multi-source pharmaceuticals and OTC products across participating state and local facilities with a March 26, 2026 proposal deadline. The code shows limited relevant recent activity consistent with its stated commodity scope and appears to be populated with pharmaceutical and health-services procurement that does not match the topical analgesic product line the code nominally describes.